Home
Companies
Bayer
Clinical Trials

Clinical Trials Related to Bayer

Related studies linked through entity extraction aliases.

Study Aims to Collect Information in Routine Clinical Practice in Italy About the Number of Patients Suffering From Irregularly Heart Beats Which Are Not Caused by a Heart Valve Problem (Non-valvular Atrial Fibrillation, NVAF) Who Stopped or Changed Rivaroxaban Treatment

Status: COMPLETED
Phase: N/A

A Study to Evaluate Cooling Sensation of an Allergy Product in Adults With a History of Allergies

Status: COMPLETED
Phase: PHASE4

Study to Compare the Effects of Drug Darolutamide and Drug Enzalutamide on Physical Function, Including Balance and Daily Activity, in Patients With Castration-resistant Prostate Cancer (CRPC)

Status: TERMINATED
Phase: PHASE2

Copanlisib and Combination Chemotherapy for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Relapsed Grade 3b Follicular Lymphoma

Status: TERMINATED
Phase: PHASE1

Bendamustine and Rituximab in Combination With Copanlisib for the Treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Status: TERMINATED
Phase: PHASE2

CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS)

Status: RECRUITING
Phase: N/A

A First in Human Study of BAY2701439 to Look at Safety, How the Body Absorbs, Distributes and Excretes the Drug, and How Well the Drug Works in Participants With Advanced Cancer Expressing the HER2 Protein

Status: COMPLETED
Phase: PHASE1

Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body

Status: RECRUITING
Phase: N/A

Study to Gather Information on the Safety and Use of Aflibercept Injections Into the Eye for the Treatment of Eye Disorders in Mexican Routine Clinical Practice

Status: COMPLETED
Phase: N/A

Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

Study to Find Out the Optimal Dose of Caffeine in the Combination Tablet of Naproxen Sodium and Caffeine in Patients Experiencing Moderate to Severe Pain After Having Wisdom Teeth Removed

Status: COMPLETED
Phase: PHASE2

Study on the Effectiveness and Safety of the Combination of the Two Drugs Regorafenib and Nivolumab in Patients With Colorectal Cancer (Cancer of the Colon or Rectum Classified as Proficient Mismatch Repair and Microsatellite Stable)

Status: COMPLETED
Phase: PHASE2

Safety, Tolerability, and Efficacy of Aflibercept in Patients With Neovascular Age-Related Macular Degeneration

Status: COMPLETED
Phase: PHASE2

Roll-over Study to Continue Treatment With the Investigational Drug Rogaratinib and to Further Test Its Safety

Status: COMPLETED
Phase: PHASE2

A Study in Which Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) Patients for Whom a Decision to Treat With Darolutamide Has Been Made Before Enrollment Are Observed and Certain Outcomes Are Described

Status: ACTIVE_NOT_RECRUITING
Phase: N/A

Treat and Extend Analysis Trial With Aflibercept in Wet-AMD

Status: UNKNOWN
Phase: PHASE3

Burden of Ischemic Stroke and Intake of Oral Anticoagulants in Patients With Atrial Fibrillation in the UK Primary Care

Status: COMPLETED
Phase: N/A

Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels

Status: COMPLETED
Phase: N/A

Rivaroxaban in Elderly NVAF Patients With or Without Renal Impairment

Status: UNKNOWN
Phase: N/A

Study to Test How Well Patients With Advanced Solid Tumors Respond to Treatment With the Elimusertib in Combination With Pembrolizumab, to Find the Optimal Dose for Patients, How the Drug is Tolerated and the Way the Body Absorbs, Distributes and Discharges the Drug

Status: COMPLETED
Phase: PHASE1